La semaglutida es un medicamento agonista del receptor del pptido similar al glucagn tipo 1 (GLP-1), aprobado por la FDA para el tratamiento de la diabetes tipo 2 y, en dosis ms altas, para el manejo crnico del peso
Relative to those in the placebo group, those treated with semaglutide took significantly fewer drinks on days they consumed alcohol, and reported greater reductions in heavy drinking days during the trial
This helps your body release insulin when glucose is high, reduces glucagon, slows stomach emptying, and can lower appetite
El GLP-1 es una hormona fisiolgica que desempea diversas funciones en la regulacin de la glucosa y el apetito, as como en el sistema cardiovascular
Clinical trials have demonstrated a reduced risk of major adverse cardiovascular events, such as heart attack and stroke, in individuals treated with semaglutide